IRF-2 regulates NF-κB activity by modulating the subcellular localization of NF-κB

Biochemical and Biophysical Research Communications

Volumn 370, Issue 3, 2008, Pages 519-524

  Chae, Myounghee ^a   Kim, Kwangsoo ^a   Park, Sun Mi ^a,c   Jang, Ik Soon ^a   Seo, Taegun ^b   Kim, Dong Min ^c   Kim, Il Chul ^c   Lee, Je Ho ^d   Park, Junsoo ^a  

^a Korea Basic Science Institute (KBSI)   (South Korea)

^b Dongguk University   (South Korea)

^c Chonnam National University   (South Korea)

^d Sungkyunkwan University   (South Korea)

Author keywords

I B ; IRF 2; NF B; RelA; TNF

Indexed keywords

I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON REGULATORY FACTOR 2; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; CARCINOGENESIS; CELL PROLIFERATION; CELL STRAIN HEK293; CELLULAR DISTRIBUTION; CONTROLLED STUDY; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; RNA INTERFERENCE; SIGNAL TRANSDUCTION;

CELL LINE; CELL NUCLEUS; HUMANS; INTERFERON REGULATORY FACTOR-2; RNA, SMALL INTERFERING; SEQUENCE DELETION; TRANSCRIPTION FACTOR RELA; TRANSCRIPTION, GENETIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 42749097884     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2008.03.136     Document Type: Article

References (18)

1. Perkins N.D. Integrating cell-signalling pathways with NF-kappaB and IKK function. Nat. Rev. Mol. Cell. Biol. 8 (2007) 49-62
2. Karin M. Nuclear factor-kappaB in cancer development and progression. Nature 441 (2006) 431-436
3. Basseres D.S., and Baldwin A.S. Nuclear factor-kappaB and inhibitor of kappaB kinase pathways in oncogenic initiation and progression. Oncogene 25 (2006) 6817-6830
4. Jost P.J., and Ruland J. Aberrant NF-kappaB signaling in lymphoma: mechanisms, consequences, and therapeutic implications. Blood 109 (2007) 2700-2707
5. Biswas D.K., Shi Q., Baily S., Strickland I., Ghosh S., Pardee A.B., and Iglehart J.D. NF-kappa B activation in human breast cancer specimens and its role in cell proliferation and apoptosis. Proc. Natl. Acad. Sci. USA 101 (2004) 10137-10142
6. Finco T.S., Westwick J.K., Norris J.L., Beg A.A., Der C.J., and Baldwin Jr. A.S. Oncogenic Ha-Ras-induced signaling activates NF-kappaB transcriptional activity, which is required for cellular transformation. J. Biol. Chem. 272 (1997) 24113-24116
7. Taniguchi T., Ogasawara K., Takaoka A., and Tanaka N. IRF family of transcription factors as regulators of host defense. Annu. Rev. Immunol. 19 (2001) 623-655
8. Harada H., Fujita T., Miyamoto M., Kimura Y., Maruyama M., Furia A., Miyata T., and Taniguchi T. Structurally similar but functionally distinct factors, IRF-1 and IRF-2, bind to the same regulatory elements of IFN and IFN-inducible genes. Cell 58 (1989) 729-739
9. Watanabe N., Sakakibara J., Hovanessian A.G., Taniguchi T., and Fujita T. Activation of IFN-beta element by IRF-1 requires a posttranslational event in addition to IRF-1 synthesis. Nucleic Acids Res. 19 (1991) 4421-4428
10. Harada H., Kitagawa M., Tanaka N., Yamamoto H., Harada K., Ishihara M., and Taniguchi T. Anti-oncogenic and oncogenic potentials of interferon regulatory factors-1 and -2. Science 259 (1993) 971-974
11. Taniguchi T., Lamphier M.S., and Tanaka N. IRF-1: the transcription factor linking the interferon response and oncogenesis. Biochim. Biophys. Acta 1333 (1997) M9-M17
12. Yim J.H., Wu S.J., Lowney J.K., Vander Velde T.L., and Doherty G.M. Enhancing in vivo tumorigenicity of B16 melanoma by overexpressing interferon regulatory factor-2: resistance to endogenous IFN-gamma. J. Interferon Cytokine Res. 19 (1999) 723-729
13. Wang Y., Liu D.P., Chen P.P., Koeffler H.P., Tong X.J., and Xie D. Involvement of IFN regulatory factor (IRF)-1 and IRF-2 in the formation and progression of human esophageal cancers. Cancer Res. 67 (2007) 2535-2543
14. Suk K., Chang I., Kim Y.H., Kim S., Kim J.Y., Kim H., and Lee M.S. Interferon gamma (IFN-gamma) and tumor necrosis factor alpha synergism in ME-180 cervical cancer cell apoptosis and necrosis. IFNgamma inhibits cytoprotective NF-kappa B through STAT1/IRF-1 pathways. J. Biol. Chem. 276 (2001) 13153-13159
15. Guttridge D.C., Albanese C., Reuther J.Y., Pestell R.G., and Baldwin Jr. A.S. NF-kappaB controls cell growth and differentiation through transcriptional regulation of cyclin D1. Mol. Cell. Biol. 19 (1999) 5785-5799
16. Hinz M., Krappmann D., Eichten A., Heder A., Scheidereit C., and Strauss M. NF-kappaB function in growth control: regulation of cyclin D1 expression and G0/G1-to-S-phase transition. Mol. Cell. Biol. 19 (1999) 2690-2698
17. Drew P.D., Franzoso G., Carlson L.M., Biddison W.E., Siebenlist U., and Ozato K. Interferon regulatory factor-2 physically interacts with NF-kappa B in vitro and inhibits NF-kappa B induction of major histocompatibility class I and beta 2-microglobulin gene expression in transfected human neuroblastoma cells. J. Neuroimmunol. 63 (1995) 157-162
18. Park M., Yong Y., Choi S.W., Kim J.H., Lee J.E., and Kim D.W. Constitutive RelA activation mediated by Nkx3.2 controls chondrocyte viability. Nat. Cell. Biol. 9 (2007) 287-298